Lara McGrath

Lara McGrath

Company: AstraZeneca

Job title: Director - Translational Medicine


Advancing AstraZeneca’s Clinically Active EGFR/MET Bispecific ADC in Phase I of Development 3:45 pm

Sharing data on the development of a bispecific ADC targeting EGGFR & MET Leveraging a Topoisomerase I inhibitor and two ligand recruitment mechanism of action for improved efficacy Exploring how AstraZeneca’s bispecific ADC is progressing through clinical developmentRead more

day: Conference Day One PM

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.